Skip to content

Clinical trials

Phase 1/2 Breast Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 1/2 Clear all

644 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200011
20019
20027
20037
200415
200513
200618
200726
200828
200932
201024
201111
201214
201310
201424
201533
201628
201733
201825
201934
202026
202124
202232
202339
202428
202535
202634

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed268
Terminated104
Recruiting94
Unknown status60
Active, not recruiting48
Withdrawn34
Not yet recruiting31
Enrolling by invitation3
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)23
Memorial Sloan Kettering Cancer Center12
Novartis Pharmaceuticals12
Pfizer11
M.D. Anderson Cancer Center10
National University Hospital, Singapore10
AstraZeneca9
University of Washington8
Fuda Cancer Hospital, Guangzhou7
Fudan University7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms644
Ovarian Neoplasms80
Neoplasm Metastasis60
Triple Negative Breast Neoplasms57
Carcinoma, Non-Small-Cell Lung54
Colorectal Neoplasms49
Pancreatic Neoplasms44
Prostatic Neoplasms43
Lung Neoplasms42
Neoplasms41

Trials

Showing 26 to 50 of 644. Each trial links to its page on Pharma Observatory.

544 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.